Holen Sie sich die Stockscreener-App
8.04
0.63%
0.05
Handel nachbörslich:
7.82
-0.22
-2.74%
Schlusskurs vom Vortag:
$7.99
Offen:
$7.61
24-Stunden-Volumen:
201.03K
Relative Volume:
0.08
Marktkapitalisierung:
$15.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+15.68%
1M Leistung:
+76.70%
6M Leistung:
+102.01%
1J Leistung:
+0.00%
1-Tages-Spanne:
$7.60
$8.35
1-Wochen-Bereich:
$6.4519
$12.45
52-Wochen-Spanne:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Vergleichen Sie QNTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
8.04 | 15.34M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Quantum Biopharma Ltd Aktie (QNTM) Neueste Nachrichten
Quantum Biopharma to Jointly Study Demyelination Imaging Technique With Massachusetts Hospital - MarketScreener
Quantum BioPharma Announces Joint Clinical Study With - GlobeNewswire
Game-Changing MS Detection: Quantum's New PET Technology Could Outperform Traditional MRI - Stock Titan
Quantum BioPharma completes $5 million funding round By Investing.com - Investing.com Canada
Quantum BioPharma in Joint Clinical Study With Massachusetts Hospital to Assess PET Imaging - MarketScreener
Quantum BioPharma completes $5 million funding round - Investing.com India
Quantum BioPharma Secures Final Tranche of $5 Million Financing - TipRanks
Quantum Biopharma Announces Closing of Final $2.42 Million - GlobeNewswire
Quantum BioPharma Closes $5M Deal While Unveiling Revolutionary Emergency Alcohol Treatment - Stock Titan
Quantum BioPharma Invests $65K in Enhanced Investor Communications Strategy - Stock Titan
Promising Biotech Stocks To Watch Now – March 28th - Defense World
Quantum BioPharma reports progress in drug trials By Investing.com - Investing.com South Africa
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Monolithic Power Systems, Inc. (MPWR) - The Globe and Mail
Quantum BioPharma pushes clinical pipeline after rebranding - Green Market Report
Quantum BioPharma reports progress in drug trials - Investing.com
Quantum BioPharma stock soars on removal of uncertainty related to going concern - Investing.com
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern - Bluefield Daily Telegraph
Quantum Biopharma Achieves Financial Milestone: Going Concern Warning Lifted as Clinical Trials Show Promise - Stock Titan
Quantum BioPharma Reports Strong 2024 Financials and Advances in Clinical Trials - TipRanks
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working - Bluefield Daily Telegraph
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern - GlobeNewswire
BiomednewsbreaksQuantum Biopharma Ltd. (NASDAQ: QNTM) Reports Q4 And Full-Year 2024 Financial Results, Highlights Breakthroughs In Alcohol Detox And MS Treatments - MENAFN.COM
Quantum BioPharma adds Terry Lynch to its board By Investing.com - Investing.com South Africa
SPY ETF News, 3/27/2025 - The Globe and Mail
AgriForce Growing Systems to Participate in Entrepreneurs’ Organization Event at Morgan Stanley’s New York City Offices - The Globe and Mail
Quantum BioPharma adds Terry Lynch to its board - Investing.com India
Quantum BioPharma Strengthens Board with Terry Lynch Appointment - TipRanks
Quantum Biopharma Announces Leading Crusader Against Naked - GlobeNewswire
Market Integrity Champion Terry Lynch Strengthens Quantum BioPharma Leadership - Stock Titan
3 Reasons to Sell RELL and 1 Stock to Buy Instead - The Globe and Mail
Quantum BioPharma's Licensee Introduces New Alcohol Detox Packs in the US - MarketScreener
Quantum BioPharma (QNTM) Stock Rallies Following Key Business Development - Stocks Telegraph
Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd™ Alcohol Detox Product Lineup for Retail Sales - Quantisnow
Global Weather Concerns Support Coffee Prices - The Globe and Mail
Quantum BioPharma Ltd expected to post a loss of 80 cents a shareEarnings Preview - TradingView
2 ‘Strong Buy’ Tech Stocks Poised for 81% to 110% Gains, According to Wall Street - The Globe and Mail
Every Plug Power Investor Should Keep an Eye on This Number - The Globe and Mail
Sandpiper Asset Management selling at Extendicare (EXE) - The Globe and Mail
Quantum BioPharma Ltd - Stockhouse Publishing
Quantum BioPharma Boosts Crypto Holdings to $3.5M, Eyes Digital Transactions - TradingPedia
Quantum BioPharma Ltd. Expands Cryptocurrency Holdings by $1.5 Million, Totaling $3.5 Million in Bitcoin and Alternatives - Nasdaq
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies - The Manila Times
Quantum BioPharma Continues to Grow Its Crypto Assets and - GlobeNewswire
Quantum Biopharma Continues To Grow Its Crypto Assets And Diversify Its Treasury With The Purchase Of Another USD $1,500,000 Worth Of Bitcoin (BTC) And Other Cryptocurrencies - MENAFN.COM
Quantum BioPharma Doubles Down on Crypto Strategy: Adds $1.5M in Bitcoin to Treasury - StockTitan
Denison Announces Appointment of Former OPG CEO Ken Hartwick to its Board of Directors - The Globe and Mail
Cannabis Stocks To Follow Today – March 18th - Defense World
GIS Earnings: Macro Issues Weigh Down General Mills Stock - The Globe and Mail
Quantum BioPharma Unaware of Any Material Change - Newsfile
Public market insider buying at National Bank of Canada (NA) - The Globe and Mail
The Smartest Vanguard ETF to Buy With $1,000 Right Now - The Globe and Mail
Finanzdaten der Quantum Biopharma Ltd-Aktie (QNTM)
Es liegen keine Finanzdaten für Quantum Biopharma Ltd (QNTM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.06%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):